Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 30.29% vs 31.92% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is -15.03% vs -1.26% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 73.31% vs -23.37% in Mar 2024
Compare Balance Sheet Results of Parmax Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
4.45
4.66
-0.21
-4.51%
Share Warrants & Outstandings
Total Reserve
-6.44
5.29
-11.73
-221.74%
Shareholder's Funds
-1.99
9.96
-11.95
-119.98%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
8.09
3.04
5.05
166.12%
Secured Loans
5.10
0.74
4.36
589.19%
Unsecured Loans
2.99
2.30
0.69
30.00%
Deferred Tax Assets / Liabilities
-0.19
0.00
-0.19
0.00%
Other Long Term Liabilities
0.00
0.04
-0.04
-100.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
7.51
3.08
4.43
143.83%
Current Liabilities
Trade Payables
10.22
4.72
5.50
116.53%
Other Current Liabilities
2.24
0.06
2.18
3,633.33%
Short Term Borrowings
0.00
0.00
0.00
0.00%
Short Term Provisions
0.59
0.17
0.42
247.06%
Total Current Liabilities
13.04
4.94
8.10
163.97%
Total Liabilities
18.56
17.98
0.58
3.23%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
17.69
13.84
3.85
27.82%
Less: Accumulated Depreciation
9.72
6.00
3.72
62.00%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
7.97
7.84
0.13
1.66%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
1.87
-1.87
-100.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.40
0.05
0.35
700.00%
Long Term Loans & Advances
0.18
0.01
0.17
1,700.00%
Other Non Current Assets
0.00
0.24
-0.24
-100.00%
Total Non-Current Assets
8.56
10.00
-1.44
-14.40%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
3.31
0.19
3.12
1,642.11%
Sundry Debtors
1.28
7.35
-6.07
-82.59%
Cash and Bank
0.09
0.07
0.02
28.57%
Other Current Assets
0.00
0.00
0.00
0.00%
Short Term Loans and Advances
5.32
0.36
4.96
1,377.78%
Total Current Assets
10.00
7.97
2.03
25.47%
Net Current Assets (Including Current Investments)
-3.03
3.04
-6.07
-199.67%
Total Current Assets Excluding Current Investments
10.00
7.97
2.03
25.47%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
18.56
17.98
0.58
3.23%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
7.32
3.04
4.28
140.79%
Book Value per share (adjusted)
-4.47
21.23
-25.70
-121.06%
Annual - Borrowings
Borrowings 7.70 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 30.29% vs 31.92% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 7.97 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -15.03% vs -1.26% in Mar 2024
Annual - Investments
Investments 0.40 Cr
in Mar 2025Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 10.00 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 73.31% vs -23.37% in Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
